Analytical Data
-
Gene name
C6orf106
- Application
-
Alternative Names
C6orf106; CF106_HUMAN; Chromosome 6 open reading frame 106; dJ391O22.4; FLJ22195; RP3-391O22.4; Uncharacterized Protein C6orf106
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H6K1
-
Expression Region
1-298aa
-
AA Sequence
MEGMDVDLDP ELMQKFSCLG TTDKDVLISE FQRLLGFQLN PAGCAFFLDM TNWNLQAAIG AYYDFESPNI SVPSMSFVED VTIGEGESIP PDTQFVKTWR IQNSGAEAWP PGVCLKYVGG DQFGHVNMVM VRSLEPQEIA DVSVQMCSPS RAGMYQGQWR MCTATGLYYG DVIWVILSVE VGGLLGVTQQ LSSFETEFNT QPHRKVEGNF NPFASPQKNR QSDENNLKDP GGSEFDSISK NTWAPAPDTW APAPDQTEQD QNRLSQNSVN LSPSSHANNL SVVTYSKGLH GPYPFGQS
-
Molecular Weight
59.3 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C6orf106, also known as chromosome 6 open reading frame 106, is a protein-coding gene that has garnered interest in the fields of genetics and molecular biology due to its potential involvement in various physiological and pathological processes. Initial studies suggest that C6orf106 may play a role in cellular signaling pathways, immunity, and possibly in the regulation of gene expression. Given the increasing evidence linking dysregulation of protein-coding genes to a range of diseases, including cancer and autoimmune disorders, researchers have focused on understanding the structure and function of the C6orf106 protein. Recombinant technology has enabled the production of C6orf106 in vitro, facilitating detailed biochemical characterization and functional assays. This research aims to elucidate the protein's role in cellular mechanisms and its potential as a biomarker or therapeutic target. By employing techniques such as site-directed mutagenesis, circular dichroism, and co-immunoprecipitation, scientists are investigating the interactions and pathways involving C6orf106. Overall, the study of C6orf106 recombinant protein represents a significant step toward comprehensively understanding its biological importance and potential contributions to human health.
